StockData
Cytosorbents Corp logo

Cytosorbents Corp (CTSO) stock

CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 19, 2026Score 2/30
$5.57+1.05 (+23.12%)

Close on Nov 18, 2026Market cap $349.72MP/E –Yield –

Cytosorbents revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Cytosorbents's revenue for the twelve months ending Sep 30, 2026 was $37.46M, up 1.3% year over year. For fiscal 2025 it was $37.06M, up 4.1% from the year before. Over ten years it grew 22.7% a year on average. The highest annual figure on record is $43.17M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$37.06M+4.1%
FY2024Dec 31, 2024$35.60M+14.5%
FY2023Dec 31, 2023$31.08M-10.4%
FY2022Dec 31, 2022$34.69M-19.6%
FY2021Dec 31, 2021$43.17M+5.3%
FY2020Dec 31, 2020$41.00M+64.4%
FY2019Dec 31, 2019$24.95M+10.9%
FY2018Dec 31, 2018$22.50M+48.5%
FY2017Dec 31, 2017$15.15M+59.0%
FY2016Dec 31, 2016$9.53M+98.8%
FY2015Dec 31, 2015$4.79M+16.2%
FY2014Dec 31, 2014$4.12M+70.2%
FY2013Dec 31, 2013$2.42M+80.4%
FY2012Dec 31, 2012$1.34M+3622.3%
FY2011Dec 31, 2011$36.08K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$9.73M+2.6%
Q2 FY2026Jun 30, 2026$9.63M+0.2%
Q1 FY2026Mar 31, 2026$8.86M+1.6%
Q4 FY2025Dec 31, 2025$9.23M+0.9%
Q3 FY2025Sep 30, 2025$9.49M+10.1%
Q2 FY2025Jun 30, 2025$9.62M+8.8%
Q1 FY2025Mar 31, 2025$8.73M-2.9%
Q4 FY2024Dec 31, 2024$9.15M+5.6%
Q3 FY2024Sep 30, 2024$8.61M-2.2%
Q2 FY2024Jun 30, 2024$8.84M-6.1%
Q1 FY2024Mar 31, 2024$8.99M-4.9%
Q4 FY2023Dec 31, 2023$8.67M-7.7%
Q3 FY2023Sep 30, 2023$8.81M+8.6%
Q2 FY2023Jun 30, 2023$9.42M+10.9%
Q1 FY2023Mar 31, 2023$9.45M+8.7%
Q4 FY2022Dec 31, 2022$9.39M-12.9%
Q3 FY2022Sep 30, 2022$8.11M-16.9%
Q2 FY2022Jun 30, 2022$8.50M-29.3%
Q1 FY2022Mar 31, 2022$8.69M-18.0%
Q4 FY2021Dec 31, 2021$10.78M-9.8%
Q3 FY2021Sep 30, 2021$9.76M-7.5%
Q2 FY2021Jun 30, 2021$12.02M+22.8%
Q1 FY2021Mar 31, 2021$10.60M+21.7%
Q4 FY2020Dec 31, 2020$11.96M+60.9%
Q3 FY2020Sep 30, 2020$10.55M+73.0%
Q2 FY2020Jun 30, 2020$9.79M+57.2%
Q1 FY2020Mar 31, 2020$8.71M+67.7%
Q4 FY2019Dec 31, 2019$7.43M+22.2%
Q3 FY2019Sep 30, 2019$6.10M+6.1%
Q2 FY2019Jun 30, 2019$6.23M+8.3%
Q1 FY2019Mar 31, 2019$5.19M+5.4%
Q4 FY2018Dec 31, 2018$6.08M+30.9%
Q3 FY2018Sep 30, 2018$5.74M+50.2%
Q2 FY2018Jun 30, 2018$5.76M+61.4%
Q1 FY2018Mar 31, 2018$4.92M+58.2%
Q4 FY2017Dec 31, 2017$4.65M+50.7%
Q3 FY2017Sep 30, 2017$3.82M–
Q2 FY2017Jun 30, 2017$3.57M–
Q1 FY2017Mar 31, 2017$3.11M–
Q4 FY2016Dec 31, 2016$3.08M–

More Cytosorbents figures

See a number that looks wrong?